Second-Line Treatment for Metastatic Hormone Refractory Prostate Cancer

Share this content:

For the first time, it appears there is a second-line treatment option for men with metastatic hormone refractory prostate cancer.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters